Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series-Reference-Cited by-同舟云学术

Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series

Published:2017-10 Issue:4 Volume:153 Page:1165-1166
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Childs-Kean Lindsey M.,Hong Joseph^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference8 articles.

1. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

2. Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

3. Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

4. Utility of Hepatitis C Viral Load Monitoring on Direct-Acting Antiviral Therapy

5. Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?;Antiviral Research;2023-12

2. Consensus Treatment Guidelines and Recommendations to Treat Hepatitis-C Infected Populations;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

3. Consensus-based Approaches for Hepatitis C Screening and Diagnosis in General and Vulnerable Populations;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

4. Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy;BMC Infectious Diseases;2020-08-26

5. ¿Qué sabemos acerca de la carga viral detectable al final del tratamiento de virus de hepatitis C con respuesta viral subsecuente?;Revista de Gastroenterología de México;2019-10